Skip to main content

PPD Reported Strong Q3 Revenue, Net Profit Growth

NEW YORK, Oct. 16 - PPD said that strong revenue growth in the third quarter surpassed a mild up tick in R&D spending, helping to drive a surge in net profits.

 

For the period ended Sept. 30, PPD said total revenue were $157.3 million, up from $115.8 million one year ago. R&D in the quarter increased to just under $3 million from 1.4 million year over year.

 

As a result, the company said that net profits in the third quarter 2002 climbed to $18.3 million, or $.33 per share, from $11.5 million, or $.22 per share, in the same quarter one year ago.

 

PPD said it had around $147 million in cash and cash equivalents as of Sept. 30.

 

Click here for more information.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.